Why is "Chronic myelogenous leukemia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-29 08:02:59
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Chronic_myelogenous_leukemia entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-29 and was most recently seen on 2026-03-29.
Wikipedia Overview
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. CML is a clonal bone marrow stem cell disorder in which a proliferation of mature granulocytes and their precursors is found; characteristic increase in basophils is clinically relevant. It is a type of myeloproliferative neoplasm associated with a characteristic chromosomal translocation called the Philadelphia chromosome.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology - Medscape
-
Trends and Cost Effectiveness of Allogeneic Stem Cell Transplant in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy. - European Society of Medicine
-
The Evolution of Tyrosine Kinase Inhibitor Therapy: Improving Outcomes in Patients with Newly Diagnosed Chronic Myelogenous Leukemia - Journal of Hematology Oncology Pharmacy
-
Chronic Myelogenous Leukemia - CancerNetwork
-
Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD - AJMC
-
Prospect of shorter treatment and cure for chronic myelogenous leukemia - Harvard Gazette
-
Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? - ASCO Publications
-
Chronic myelogenous leukemia: mechanisms underlying disease progression - Nature
-
Chronic Myelogenous Leukemia: What Drug for Which Patient? - The ASCO Post
-
Nilotinib Can Be Discontinued in Some Patients with Chronic Myelogenous Leukemia - National Cancer Institute (.gov)
-
Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy - Haematologica
-
Understanding Chronic Myelogenous Leukemia (CML) - Moffitt
-
Asciminib a new player in treatment of TKI-resistant/intolerant chronic phase chronic myelogenous leukemia - Via Medica Journals
-
BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia - NEJM
-
Chronic Myelogenous Leukemia (CML): 5 Things to Know - Medscape
-
Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells - Nature
-
Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia - Haematologica
-
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib - Nature
-
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis - Nature
-
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia - Nature
-
FDA Approves Dasatinib for Some Children with CML - National Cancer Institute (.gov)
-
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL -positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib - Nature
-
BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia - NEJM
-
Chronic Myelogenous Leukemia Classification - News-Medical
-
Chronic Myelogenous Leukemia Prognosis - News-Medical
-
New Path for Preventing Chronic Myelogenous Leukemia Relapse Discovered - genengnews.com
-
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia - Nature
-
Chronic myelogenous leukemia presenting with Morel Lavallée lesion: A case report of a rare presentation - Wiley Online Library
-
CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells - Nature
-
Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia - Nature
-
Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia - NEJM
-
Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia - Cureus
-
Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia - news.cancerconnect.com
-
Chronic Myelogenous Leukemia with Gastric Infiltration — Report of a Case Simulating Carcinoma of the Stomach - NEJM
-
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice - Nature
-
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia - Nature
-
Selecting Treatment for Newly Diagnosed CML - Oncology News Central
-
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies - Nature
-
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia - Frontiers
-
Bilateral intracochlear hemorrhage: A rare onset of chronic myelogenous leukemia - Wiley Online Library
-
Spontaneous Remission in a Patient with Chronic Myelogenous Leukemia - NEJM
-
Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter? - Taylor & Francis Online
-
Diagnosis of Chronic Myelogenous Leukemia in a Dog Using Morphologic, Cytochemical, and Flow Cytometric Techniques - Wiley Online Library
-
A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib - Tomassetti - 2022 - Clinical Case Reports - Wiley Online Library
-
Cancer - National Institutes of Health (NIH) | (.gov)
-
Detection and quantification of residual disease in chronic myelogenous leukemia - Nature
-
Chronic Myelogenous Leukemia (CML): Amanda's Story - BMT infonet.org
-
Complete Molecular Remission in Chronic Myelogenous Leukemia after Imatinib Therapy - NEJM
-
Complete cytogenetic and molecular responses to interferon-α-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis - Wiley & Sons
-
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects - Nature
-
Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway - Nature
-
Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells - Nature
-
Cord-Blood Transplantation from an Unrelated Donor in an Adult with Chronic Myelogenous Leukemia - NEJM
-
Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib - Nature
-
Antibody eradicates leukemia stem cells - Newsroom | UCLA
-
BCR-ABL %IS Kit Monitors CML Treatment Response - Clinical Lab Products
-
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation - Nature
-
A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia - NEJM
-
Panniculitis during Dasatinib Therapy for Imatinib-Resistant Chronic Myelogenous Leukemia - NEJM
-
Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter? - Taylor & Francis Online
-
Gata2 -L359V impairs primitive and definitive hematopoiesis and blocks cell differentiation in murine chronic myelogenous leukemia model - Nature
-
Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase - Nature
-
Myelolipoma/extramedullary hematopoiesis within adrenal cortical adenoma increased in size during chronic myelogenous leukemia treatment - Springer Nature Link
-
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia - NEJM
-
FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML - Cure Today
-
Novel structural co-expression analysis linking the NPM1 -associated ribosomal biogenesis network to chronic myelogenous leukemia - Nature
-
How do harmful chronic myelogenous leukemia stem cells obtain their nutrients? - EurekAlert!
-
Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance - Nature
-
Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia - Wiley & Sons
-
Surprising Results Change Treatment Approach in CML - Oncology News Central
-
How do harmful chronic myelogenous leukemia stem cells obtain their nutrients? - Medical Xpress
-
FDA Approves Nilotinib Formulation (Danziten) for Chronic Myeloid Leukemia - Oncology News Central
-
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy - Nature
-
Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CML - National Cancer Institute (.gov)
-
Atraumatic splenic rupture as an initial presentation of chronic myelogenous leukemia - MDEdge
-
How Gleevec Transformed Leukemia Treatment - National Cancer Institute (.gov)
-
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model - Nature
-
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy - Wiley & Sons
-
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi( ϕ )-LMC GROUP) - Nature
-
Persistent bloody tears as the initial manifestation of conjunctival chloroma associated with chronic myelogenous leukemia - Springer Nature Link
-
Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells - Nature
-
Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia - Nature
-
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients - Nature
-
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate - Nature
-
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr abl negative chronic myelogenous leukemia - Wiley & Sons
-
Airman beats leukemia into remission - moody.af.mil
-
Dysplastic basophils in the accelerated phase of chronic myelogenous leukemia - Wiley Online Library
-
Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy - Nature
-
FDA Approves New Imatinib (Imkeldi) Formulation for Various Cancer Types - Oncology News Central
-
Discontinuation of nilotinib treatment in a patient with chronic myelogenous leukemia and thrombocytopenia induced by imatinib | Grzybowska-Izydorczyk | Hematology in Clinical Practice - Via Medica Journals
-
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia - Korea Biomedical Review
-
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia - Nature
-
NBA Legend Kareem Abdul-Jabbar, 78, Was Terrified of His Chronic Myelogenous Leukemia (CML) Diagnosis— How He's Effectively Managing The Disease - SurvivorNet
-
Further phenotypic characterization of the primitive lineage− CD34+CD38−CD90+CD45RA− hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia - Nature
-
Is chronic myeloid leukemia hereditary? - Medical News Today
-
New way to halt leukemia relapse shown promising in mice - Asia Research News |
-
Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia - Nature
-
Myeloproliferative Disorders Drugs Market Report, 2025-2030 - Grand View Research
-
Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia | NEJM - NEJM
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.